Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study

J M van Woerkom(University Medical Center Utrecht), J. W. J. Bijlsma(University Medical Center Utrecht), Suzanne Verstappen(Arthritis UK), Roel Goldschmeding(University Medical Center Utrecht), Joël A. G. van Roon(Utrecht University), Aike A. Kruize(Utrecht University), Rinie Geenen(Utrecht University), Eric N. van Roon(Medisch Centrum Leeuwarden)
Annals of the Rheumatic Diseases
January 13, 2007
10.1136/ard.2006.060905
Cited by 100

Related Papers

EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
Psychological adjustment to chronic disease
|The Lancet|2008|754
EULAR definition of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2020|538
EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritis
|Annals of the Rheumatic Diseases|2018|370
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
|Annals of the Rheumatic Diseases|2016|331